Stem Cell Firm Cryo-Save Group Forms Genomics, Proteomics Business Unit | GenomeWeb

NEW YORK (GenomeWeb) – Stem cell storage company Cryo-Save Group today announced the formation of a business unit focused on predictive medicine using genomics and proteomics technologies.

The creation of the unit, called Genoma, is part of a wide-ranging reorganization of Cryo-Save's operations that also include the formation two other business units focused on cord blood and tissue cyro-preservation and translational regenerative medicine R&D.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.